The role of nitric oxide in improving endothelial function andcardiovascular health: focus on nebivolol
Although β-blockers have been endorsed by guidelines committees for the treatment of patients with hypertension, particularly those with significant CVD and high CVD risk, there are concerns about conventional β-blockers related to poorer clinical outcomes compared with other classes of antihyperten...
Main Authors: | G. L. Bakris, J. N. Basile, T. D. Giles, A. A. Taylor |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2011-04-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1914 |
Similar Items
-
The role of vasodilating β-blockers in controlling arterial hypertension as a means of reducing cardiovascular and stroke risk
by: Jan N. Basile
Published: (2011-06-01) -
The role of vasodilating β-blockers in patients with complicated hypertension: focus on nebivolol
by: T. D. Giles
Published: (2011-12-01) -
NEBIVOLOL and the 2009 ESH update to the 2007 ESH/ESC Guidelines
by: V. I. Makolkin
Published: (2010-12-01) -
Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01) -
Pleiotropic activity of antihypertensives in atherothrombogenesis. Nebivolol: increasing possibilities and reducing restrictions
by: M. G. Bubnova
Published: (2008-12-01)